Long-term exposure of mice to nucleoside analogues disrupts mitochondrial DNA maintenance in cortical neurons.
Nucleoside analogue reverse transcriptase inhibitor (NRTI), an integral component of highly active antiretroviral therapy (HAART), was widely used to inhibit HIV replication. Long-term exposure to NRTIs can result in mitochondrial toxicity which manifests as lipoatrophy, lactic acidosis, cardiomyopathy and myopathy, as well as polyneuropathy. But the cerebral neurotoxicity of NRTIs is still not well known partly due to the restriction of blood-brain barrier (BBB) and the complex microenvironment of the central nervous system (CNS). In this study, the Balb/c mice were administered 50 mg/kg stavudine (D4T), 100 mg/kg zidovudine (AZT), 50 mg/kg lamivudine (3TC) or 50 mg/kg didanosine (DDI) per day by intraperitoneal injection, five days per week for one or four months, and primary cortical neurons were cultured and exposed to 25 µM D4T, 50 µM AZT, 25 µM 3TC or 25 µM DDI for seven days. Then, single neuron was captured from mouse cerebral cortical tissues by laser capture microdissection. Mitochondrial DNA (mtDNA) levels of the primary cultured cortical neurons, and captured neurons or glial cells, and the tissues of brains and livers and muscles were analyzed by relative quantitative real-time PCR. The data showed that mtDNA did not lose in both NRTIs exposed cultured neurons and one month NRTIs treated mouse brains. In four months NRTIs treated mice, brain mtDNA levels remained unchanged even if the mtDNA levels of liver (except for 3TC) and muscle significantly decreased. However, mtDNA deletion was significantly higher in the captured neurons from mtDNA unchanged brains. These results suggest that long-term exposure to NRTIs can result in mtDNA deletion in mouse cortical neurons.
Department of Infectious Diseases, Beijing You An Hospital, Capital Medical University, Beijing, China.
Yulin
Y
Zhang
Department of Infectious Diseases, Beijing You An Hospital, Capital Medical University, Beijing, China.
Fengli
F
Song
Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.
Ziyun
Z
Gao
Department of Infectious Diseases, Beijing You An Hospital, Capital Medical University, Beijing, China.
Wei
W
Ding
Department of Infectious Diseases, Beijing You An Hospital, Capital Medical University, Beijing, China.
Luxin
L
Qiao
Department of Infectious Diseases, Beijing You An Hospital, Capital Medical University, Beijing, China.
Sufang
S
Yang
Department of Otolaryngology, The First Affiliated Hospital Of Nanjing Medical University, Nanjing, China.
Xi
X
Chen
Department of Infectious Diseases, Beijing You An Hospital, Capital Medical University, Beijing, China.
Ronghua
R
Jin
Department of Infectious Diseases, Beijing You An Hospital, Capital Medical University, Beijing, China.
Dexi
D
Chen
D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology*; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D004272:DNA, Mitochondrial / Q000378:metabolism*; D016049:Didanosine / Q000494:pharmacology; D019259:Lamivudine / Q000494:pharmacology; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D051379:Mice; D008928:Mitochondria / Q000187:drug effects* / Q000378:metabolism; D018482:Muscle, Skeletal / Q000187:drug effects / Q000378:metabolism; D009474:Neurons / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D018119:Stavudine / Q000494:pharmacology; D015215:Zidovudine / Q000494:pharmacology
D000963:Antimetabolites; D004272:DNA, Mitochondrial; D019259:Lamivudine; D015215:Zidovudine; D018119:Stavudine; D016049:Didanosine